Dermatology · Studio City, CA
NPI
1720083744
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3959 Laurel Canyon Blvd, Suite F
Studio City, CA, 91604
Phone (818) 505-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$607K
7,528 services
Medicare patients, 2024
1,331
Average age 75
Drug cost, 2024
$2.8M
4,887 prescriptions
Company payments, 2025
$50K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gennady Rubinstein was code 17003 (destruction skin lesion), 2,132 times for 298 patients. In total Gennady Rubinstein billed 7,528 services in 78 codes, and Medicare paid $607K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,132 | 298 | $5.83 | $12K |
| 99213 Office E&M - Established | Office | 952 | 672 | $73.02 | $70K |
| 17110 Destruction Skin Lesion | Office | 798 | 596 | $94.07 | $75K |
| 99214 Office E&M - Established | Office | 763 | 529 | $103.29 | $79K |
| 17000 Destruction Skin Lesion | Office | 556 | 413 | $40.64 | $23K |
| 11102 Skin Biopsy | Office | 362 | 334 | $67.29 | $24K |
| 17111 Destruction Skin Lesion | Office | 258 | 195 | $111.36 | $29K |
| 99204 Office E&M - New | Office | 171 | 171 | $130.17 | $22K |
| 99203 Office E&M - New | Office | 169 | 169 | $86.50 | $15K |
| 11900 Skin | Office | 159 | 128 | $37.99 | $6,041 |
| 17004 Destruction Skin Lesion | Office | 150 | 121 | $139.16 | $21K |
| Q4180 Revita, per square centimeter | Office | 136 | 12 | $359.12 | $49K |
| 17311 Mohs Surgery | Office | 95 | 83 | $528.27 | $50K |
| 11103 Skin Biopsy | Office | 84 | 61 | $43.49 | $3,654 |
| 10060 Skin | Office | 71 | 63 | $103.30 | $7,335 |
By year: 2022 $960K for 11,517 services; 2023 $653K for 7,958 services; 2024 $607K for 7,528 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 34 | 31 | $5.71 | $194 |
Medicare prescription drug claims, 2024
In 2024, the drug Gennady Rubinstein prescribed most often to Medicare patients was Ketoconazole, with 742 prescriptions and refills. In total Gennady Rubinstein wrote 4,887 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 742 | 762 | 151 | $15K |
| Triamcinolone Acetonide Generic | 649 | 695 | 261 | $3,687 |
| Mometasone Furoate Generic | 463 | 474 | 181 | $8,919 |
| Clobetasol Propionate Generic | 245 | 273 | 75 | $26K |
| Doxycycline Hyclate Generic | 229 | 283 | 108 | $4,306 |
| Metronidazole Generic | 169 | 173 | 41 | $16K |
| Nystatin Generic | 161 | 167 | 62 | $1,711 |
| Betamethasone Dipropionate Generic | 147 | 155 | 43 | $4,977 |
| Ivermectin Generic | 139 | 142 | 48 | $52K |
| Fluocinolone Acetonide Generic | 127 | 155 | 32 | $5,942 |
| Clindamycin Phosphate Generic | 112 | 117 | 37 | $2,364 |
| Dupixent Pen Dupilumab | 108 | 110 | 20 | $401K |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 105 | 105 | 36 | $2,355 |
| Valacyclovir Valacyclovir Hcl | 97 | 111 | 37 | $1,292 |
| Ciclopirox Ciclopirox Olamine | 94 | 96 | 32 | $1,439 |
Brand drugs: 612 claims; generic drugs: 4,275 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gennady Rubinstein $50K ($50K in general payments such as food, travel and fees) from 23 companies. The largest payer was Galderma Laboratories, L.P. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 44 | $31K |
| Abbvie Inc. ABBV | 44 | $9,451 |
| Journey Medical Corporation DERM | 6 | $4,791 |
| Amgen Inc. AMGN | 7 | $1,609 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $396 |
| Janssen Biotech, Inc. JNJ | 8 | $337 |
| LEO Pharma Inc. | 21 | $314 |
| Arcutis Biotherapeutics, Inc. ARQT | 11 | $256 |
| Genzyme Corporation SNY | 6 | $232 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.